Order Article Reprints

Laurent A, Abdel-Sayed P, Grognuz A, Scaletta C, Hirt-Burri N, Michetti M, de Buys Roessingh AS, Raffoul W, Kronen P, Nuss K, et al. Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation. Biomedicines. 2021; 9(4):380. https://doi.org/10.3390/biomedicines9040380

Laurent, Alexis, Philippe Abdel-Sayed, Anthony Grognuz, Corinne Scaletta, Nathalie Hirt-Burri, Murielle Michetti, Anthony S. de Buys Roessingh, Wassim Raffoul, Peter Kronen, Katja Nuss, and et al. 2021. "Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation" Biomedicines 9, no. 4: 380. https://doi.org/10.3390/biomedicines9040380

Laurent, A., Abdel-Sayed, P., Grognuz, A., Scaletta, C., Hirt-Burri, N., Michetti, M., de Buys Roessingh, A. S., Raffoul, W., Kronen, P., Nuss, K., von Rechenberg, B., Applegate, L. A., & Darwiche, S. E. (2021). Industrial Development of Standardized Fetal Progenitor Cell Therapy for Tendon Regenerative Medicine: Preliminary Safety in Xenogeneic Transplantation. Biomedicines, 9(4), 380. https://doi.org/10.3390/biomedicines9040380